Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab Biopharma Receives IND Approval from NMPA to Initiate Clinical Trials for its Anti-GM-CSF Monoclonal Antibody TJM2 in China 2019-11-14 23:45
China Jo-Jo Drugstores Reports Second Quarter 2020 Financial Results 2019-11-14 22:00
DOF ranks 1st in Korea Brand Preference Award for three consecutive years 2019-11-14 21:00
Samsung Biologics Enhances Its Trusted Service as the First and Only ISO27001 Certified CDMO 2019-11-14 20:00
111, Inc. Announces Third Quarter 2019 Unaudited Financial Results 2019-11-14 17:56
111 Signs Strategic Partnership with HEC Group to Strengthen Cooperation with Innovative Pharmaceutical Manufacturer 2019-11-14 16:35
China Biologic Reports Financial Results for the Third Quarter of 2019 2019-11-14 05:43
Stone Street Group Initiates Coverage On BiomX Inc. 2019-11-12 20:25
TenNor Therapeutics Reported Phase II Top-Line Results for TNP-2092 2019-11-11 21:00
Akesobio Presents Phase 1 Clinical Data from First-in-class Bispecific Drug Candidate AK104 (PD1/CTLA4) As Oral Presentation, at 2019 SITC Annual Meeting 2019-11-11 17:35
Dongpo Pickle Chased Worldwide as a Healthy Food 2019-11-11 08:00
Spectrum Therapeutics Partners with Emerald Clinics on Real World Evidence Research 2019-11-11 05:00
Ivantis Announces 3 Year Results of Australian SPECTRUM Registry for Hydrus Microstent 2019-11-08 03:00
VolitionRx Limited Schedules Third Quarter 2019 Earnings Conference Call and Business Update 2019-11-07 21:30
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost 2019-11-07 20:24
TransThera Biosciences Lead Product TT-00420 Granted Orphan Drug Designation from FDA to Treat Cholangiocarcinoma 2019-11-07 20:08
MEBO Group exhibits new products on CIIE again to promote the internationalization of traditional Chinese medicines (TCMS) 2019-11-07 14:43
Polynoma Presenting Interim Phase III Data for Its Investigational Melanoma Vaccine, Seviprotimut-L, at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2019-11-06 20:00
WuXi AppTec Receives Investment Grade Corporate Ratings from Three Global Rating Agencies 2019-11-06 16:00
Hebron Technology Co., Ltd. to Hold Annual Meeting of Shareholders on December 20, 2019 2019-11-06 05:05
1 263 264 265 266 267 787